Össur hf. - Financial Calendar

Ossur Hf : Össur Reporting Calendar 2017

 Announcement from Össur hf. No. 99/2016
 Reykjavik, 9 December 2016




                         Össur Reporting Calendar 2017

Following are the expected dates for publication of financial results for 2017:

1st Quarter - 27 April 2017

2nd Quarter - 25 July 2017

3rd Quarter - 24 October 2017

4th Quarter and Consolidated Financial Statements - 5 February 2018

Annual General Meeting - 8 March 2018



Further information:



Oskar Marus Dadason, IR Manager           Tel: +1 949 220 4550


Össur press releases by e-mail

If you wish to receive Össur press releases by e-mail please register at our
web-site: www.ossur.com/investormailings.

 About Össur

 Össur (NASDAQ OMX: OSSR) is a global leader in non-invasive orthopaedics that
 help people live a life without limitations.  Its business is focused on
 improving people's mobility through the delivery of innovative technologies
 within the fields of braces, supports, prosthetic limbs and compression
 therapy.  A recognized "Technology Pioneer", Össur invests significantly in
 research and product development; its award-winning designs ensuring a
 consistently strong position in the market. Successful patient and clinical
 outcomes are further empowered via Össur's educational programs and business
 solutions.  Headquartered in Iceland, Össur has major operations in the
 Americas, Europe and Asia, with additional distributors
 worldwide. www.ossur.com

 Forward-Looking Statements

 This press release includes "forward-looking statements" which involve risks
 and uncertainties that could cause actual results to differ materially from
 results expressed or implied by these statements. Össur hf. undertakes no
 obligation and does not intend to update these forward-looking statements to
 reflect events or circumstances occurring after this press release. You are
 cautioned not to place undue reliance on these forward-looking statements,
 which speak only as of the date of this press release. All forward-looking
 statements are qualified in their entirety by this cautionary statement.
 

[]